Collaborator
|
Institution
|
Target/Status
|
|
Capobianco
|
University of Miami
|
Identification of inhibitors of Notch
|
|
Chrysina
|
Inst. Organic & Pharmaceutical Chem. Nat. Hellenic Res. Fd. Greece
|
Glycogen phosphorylase/phosphorylase kinase, Greek Secretariat for Research and Technology,
International S & T Cooperation Directorate, Grant; submitted, active compounds identified
|
|
Coop
|
UMB, GCC, Pharmacy
|
Opioids/Analgesics, lead optimization in progress, NIH R01 funded
|
|
Melnick & Privé
|
Cornell, Toronto
|
BCL6/B-cell Lymphoma, active compounds identified; Waxman foundation funding, patent pending
|
|
Polli
|
UMB, Pharmacy
|
Bile Acid Uptake for Drug delivery, strucure optimization; NIH R01 funded
|
|
Qu
|
Case Western Reserve
|
SHP2 Phosphatase/leukemia, Active compounds identified; NIH R21 funded, Provisional patent
|
|
Shapiro
|
UMB, Pharmacy
|
ERK kinase, active compounds identified; NIH R21 funded, patent pending
|
|
Smith
|
UMB, Pharmacy
|
Rational design of inhibitors of LRRK2 kinase
|
|
Swaan
|
UMB, Pharmacy
|
Dendrimers/drug delivery, UMCP Nanomedicine Initiative funding, hASBT model development
|
|
Tomkinson
|
UMB, GCC, Medicine
|
DNA ligase/Rad50, radiotherapy enhancers, active compounds identified, provisional patent
|
|
Wang
|
UMB, Pharmacy
|
Rational design of chemical modulators of PKCI/HINT1
|
|
Weber
|
UMB, GCC, Medicine
|
S100B - p53 Interactions, Active compounds identified; ACS funded, NIH R01 funded, patent pending
|
|
Wilks
|
UMB, Pharmacy
|
Iron utilization by bacteria, Active compounds targeting Heme oxygenase identified, PhuS search ongoing, patent pending; NIH R01 submitted
|
|
Zhang & Osterman
|
UT Southwest Medical Center, Burnham Institute
|
Adenosyltransferase, active compounds identifed; NIH R01 funded
|
|
Andrade
|
Temple University
|
Novel macrolide antibiotics to overcome drug resistance
|
|
Archontis & Spiros
|
Univ. of Cyprus
|
Glycogen phosphorylase, lead optimization
|
|
DiGate
|
PCP
|
Topoisomersase, active compound identified
|
|
Hayashi
|
UMB, Pharmacy
|
p56lck kinase, active compounds identified; NIH R01, tobacco $ funded, patent pending
|
|
Neamati
|
USC, Pharmacy
|
HIV Integrase, active compounds identified, publications
|
|
Passaniti
|
UMB, GCC, Medicine
|
Runt Domain/angiogenesis; NIH R21 funded
|
|
Ross
|
UMB, GCC, Medicine
|
Hypoxia-inducible factor/solid tumors; active compounds identified
|
|
Serrero
|
UMB, Pharmacy
|
PCDGF/breast cancer, active compounds identified; DoD Concept Award Funded
|
|
Sussman
|
UMB, Pharmacy
|
β-Catenin/colon Cancer, active compounds identified; NIH R21 funded
|
